A Systematic Review of Human Trials Using Stem Cell Therapy for Erectile Dysfunction

Sexual Medicine Reviews - Tập 8 - Trang 122-130 - 2020
Soum D. Lokeshwar1, Premal Patel1, Serena M. Shah1, Ranjith Ramasamy1
1Department of Urology, University of Miami School of Medicine, Miami, Florida, USA

Tóm tắt

ABSTRACTIntroductionNovel therapeutic modalities have been proposed for the treatment and management of erectile dysfunction (ED). Stem cell therapy (SCT) is the injection of mesenchymal stem cells or stromal vascular fractions from adipose and other tissue sources. Although SCT has been studied and reported in multiple rodent trials, few human clinical trials exist.AimThe aim of this study was to provide a systematic review of SCT for the treatment of ED with an emphasis on data from peer-reviewed human studies.MethodsA systematic review was performed evaluating SCT for ED in human studies using PubMed-Medline and Scopus databases. Literature search was conducted using key words such as “Clinical Trials of SCT for ED,” “Stromal Vascular Fraction Treatment for ED,” and “SCT for ED.” Systematic review followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.Main Outcome MeasureThe main outcomes measure was the safety and efficacy of SCT for ED in humans.Results5 studies specific to SCT for ED treatment were included. A total of 61 patients were included in these phase I and II clinical trials and follow-up periods ranged from 6−62 months. End points of the studies included safety, tolerability, and efficacy of SCT for ED. The majority of the studies demonstrated improvement in erectile function due to SCT in patients, including improvements in penile vascular flow, International Index of Erectile Function-15 items, and Erectile Hardness Scale scores. All of the studies reported that there were no serious adverse events for patients. Limitations of the studies included small cohort sizes, and only 1 contained a sham arm.ConclusionThe 5 completed human clinical trials show promise for SCT as a restorative therapy for the treatment of ED. However, although promising, there still exists very limited data for the use of SCT for ED in humans. With the expansion of clinics offering SCT for ED, it is imperative that SCT is investigated further for safety, efficacy, and standardization.

Tài liệu tham khảo

National Institutes of Health, 1993, Consensus development conference statement. National Institutes of Health. Impotence. December 7–9, 1992, Int J Impot Res, 5, 181 Feldman, 1994, Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study, J Urol, 151, 54, 10.1016/S0022-5347(17)34871-1 Nguyen, 2017, Erectile dysfunction in young men—A review of the prevalence and risk factors, Sex Med Rev, 5, 508, 10.1016/j.sxmr.2017.05.004 Schulster, 2017, Metabolic syndrome and sexual dysfunction, Curr Opin Urol, 27, 435, 10.1097/MOU.0000000000000426 Ayta, 1999, The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences, BJU Int, 84, 50, 10.1046/j.1464-410x.1999.00142.x Clavijo, 2017, Effects of low-intensity extracorporeal shockwave therapy on erectile dysfunction: A systematic review and meta-analysis, J Sex Med, 14, 27, 10.1016/j.jsxm.2016.11.001 Wu, 2016, Optimization of platelet-rich plasma and its effects on the recovery of erectile function after bilateral cavernous nerve injury in a rat model, J Tissue Eng Regen Med, 10, E294, 10.1002/term.1806 Goradel, 2018, Stem cell therapy: A new therapeutic option for cardiovascular diseases, J Cell Biochem, 119, 95, 10.1002/jcb.26169 Nguyen, 2016, Adult stem cell therapy and heart failure, 2000 to 2016: A systematic review, JAMA Cardiol, 1, 831, 10.1001/jamacardio.2016.2225 Gonzalez, 2016, An update on human stem cell-based therapy in Parkinson's disease, Curr Stem Cell Res Ther, 11, 561, 10.2174/1574888X10666150531172612 Duncan, 2017, Alzheimer's disease, dementia, and stem cell therapy, Stem Cell Res Ther, 8, 111, 10.1186/s13287-017-0567-5 Im, 2017, Clinical use of stem cells in orthopaedics, Eur Cells Mater, 33, 183, 10.22203/eCM.v033a14 Bahk, 2010, Treatment of diabetic impotence with umbilical cord blood stem cell intracavernosal transplant: Preliminary report of 7 cases, Exp Clin Transplant, 8, 150 Haahr, 2018, A 12-month follow-up after a single intracavernous injection of autologous adipose-derived regenerative cells in patients with erectile dysfunction following radical prostatectomy: An open-label phase I clinical trial, Urology, 121, 10.1016/j.urology.2018.06.018 Levy, 2016, Determining the feasibility of managing erectile dysfunction in humans with placental-derived stem cells, J Am Osteopath Assoc, 116, e1 Matz, 2019, Stem cell therapy for erectile dysfunction, Sex Med Rev, 7, 321, 10.1016/j.sxmr.2017.12.008 Kaya, 2015, A comprehensive review of metabolic syndrome affecting erectile dysfunction, J Sex Med, 12, 856, 10.1111/jsm.12828 Min, 2003, Long-term improvement of cardiac function in rats after infarction by transplantation of embryonic stem cells, J Thorac Cardiovasc Surg, 125, 361, 10.1067/mtc.2003.101 Al Demour, 2018, Safety and potential therapeutic effect of two intracavernous autologous bone marrow derived mesenchymal stem cells injections in diabetic patients with erectile dysfunction: An open label phase I clinical trial, Urol Int, 101, 358, 10.1159/000492120 Fall, 2009, Apoptosis and effects of intracavernous bone marrow cell injection in a rat model of postprostatectomy erectile dysfunction, Eur Urol, 56, 716, 10.1016/j.eururo.2008.09.059 Yiou, 2016, Safety of intracavernous bone marrow-mononuclear cells for postradical prostatectomy erectile dysfunction: An open dose-escalation pilot study, Eur Urol, 69, 988, 10.1016/j.eururo.2015.09.026 Yiou, 2017, Intracavernous injections of bone marrow mononucleated cells for postradical prostatectomy erectile dysfunction: Final results of the INSTIN clinical trial, Eur Urol Focus, 3, 643, 10.1016/j.euf.2017.06.009 Mishra, 2017, Activation and differentiation of mesenchymal stem cells, Methods Mol Biol, 1554, 201, 10.1007/978-1-4939-6759-9_13 Caplan, 2015, Adult mesenchymal stem cells: When, where, and how, Stem Cells Int, 2015, 628767, 10.1155/2015/628767 Ding, 2015, Human umbilical cord mesenchymal stem cells: A new era for stem cell therapy, Cell Transplant, 24, 339, 10.3727/096368915X686841 Wei, 2013, Mesenchymal stem cells: A new trend for cell therapy, Acta Pharmacol Sin, 34, 747, 10.1038/aps.2013.50 Sipp, 2018, Clear up this stem-cell mess, Nature, 561, 455, 10.1038/d41586-018-06756-9 Han, 2015, Adipose-derived stromal vascular fraction cells: Update on clinical utility and efficacy, Crit Rev Eukaryot Gene Expr, 25, 145, 10.1615/CritRevEukaryotGeneExpr.2015013057 Bora, 2017, Adipose tissue-derived stromal vascular fraction in regenerative medicine: A brief review on biology and translation, Stem Cell Res Ther, 8, 145, 10.1186/s13287-017-0598-y Abidu-Figueiredo, 2011, The penis in diabetes: Structural analysis of connective tissue and smooth muscle alterations in a rabbit model, BJU Int, 108, 400, 10.1111/j.1464-410X.2010.09944.x Lin, 2009, Potential of adipose-derived stem cells for treatment of erectile dysfunction, J Sex Med, 6, 320, 10.1111/j.1743-6109.2008.01190.x Uccelli, 2008, Mesenchymal stem cells in health and disease, Nat Rev Immunol, 8, 726, 10.1038/nri2395 Reed-Maldonado, 2016, The current status of stem-cell therapy in erectile dysfunction: A review, World J Mens Health, 34, 155, 10.5534/wjmh.2016.34.3.155 Woo, 2011, Transplantation of muscle-derived stem cells into the corpus cavernosum restores erectile function in a rat model of cavernous nerve injury, Korean J Urol, 52, 359, 10.4111/kju.2011.52.5.359 Albersen, 2010, Injections of adipose tissue-derived stem cells and stem cell lysate improve recovery of erectile function in a rat model of cavernous nerve injury, J Sex Med, 7, 3331, 10.1111/j.1743-6109.2010.01875.x Huang, 2016, The effects of adipose-derived stem cells in a rat model of tobacco-associated erectile dysfunction, PLoS One, 11, e0156725, 10.1371/journal.pone.0156725 You, 2015, Comparative study of autologous stromal vascular fraction and adipose-derived stem cells for erectile function recovery in a rat model of cavernous nerve injury, Stem Cells Transl Med, 4, 351, 10.5966/sctm.2014-0161 Escacena, 2015, Bottlenecks in the efficient use of advanced therapy medicinal products based on mesenchymal stromal cells, Stem Cells Int, 2015, 895714, 10.1155/2015/895714 Fadini, 2017, Concise review: Perspectives and clinical implications of bone marrow and circulating stem cell defects in diabetes, Stem Cells, 35, 106, 10.1002/stem.2445 Casiraghi, 2013, Multipotent mesenchymal stromal cell therapy and risk of malignancies, Stem Cell Rev, 9, 65, 10.1007/s12015-011-9345-4 Brennen, 2017, Mesenchymal stem cell infiltration during neoplastic transformation of the human prostate, Oncotarget, 8, 46710, 10.18632/oncotarget.17362 Brennen, 2012, Quantification of mesenchymal stem cells (MSCs) at sites of human prostate cancer, Oncotarget, 4, 106, 10.18632/oncotarget.805 Schweizer, 2019, A phase I study to assess the safety and cancer-homing ability of allogeneic bone marrow-derived mesenchymal stem cells in men with localized prostate cancer, Stem Cells Transl Med, 8, 441, 10.1002/sctm.18-0230 Brennen, 2019, In Reply to the Letter to the Editor from Raj et al.: Clinical evidence indicates allogeneic mesenchymal stem cells do not pose a significant risk for cancer progression in the context of cell-based drug delivery, Stem Cells Transl Med, 8, 739, 10.1002/sctm.19-0068 Burnett, 2018, Erectile dysfunction: AUA guideline, J Urol, 200, 633, 10.1016/j.juro.2018.05.004 Krzastek, 2019, Recent advances in the understanding and management of erectile dysfunction, F1000Res, 8, 10.12688/f1000research.16576.1 Scott, 2019, Platelet-rich plasma and treatment of erectile dysfunction: Critical review of literature and global trends in platelet-rich plasma clinics, Sex Med Rev, 7, 306, 10.1016/j.sxmr.2018.12.006 U.S. Food and Drug Administration, 2017, FDA Warns About Stem Cell Therapies